Rheumatoid arthritis and Marasmus


Marasmus is found among people with Rheumatoid arthritis, especially for people who are female, 60+ old.

The study analyzes which people have Marasmus with Rheumatoid arthritis. It is created by eHealthMe based on reports of 25 people who have Rheumatoid arthritis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 17, 2022

25 people who have Rheumatoid Arthritis and Marasmus are studied.

What is Rheumatoid arthritis?

Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints) is found to be associated with 2,717 drugs and 1,950 conditions by eHealthMe.

What is Marasmus?

Marasmus (severe malnutrition characterized by energy deficiency) is found to be associated with 264 drugs and 153 conditions by eHealthMe.

Number of Marasmus in Rheumatoid arthritis reports submitted per year:

Would you have Marasmus when you have Rheumatoid arthritis?

Gender of people who have Rheumatoid Arthritis and experienced Marasmus *:

  • female: 61.9 %
  • male: 38.1 %

Age of people who have Rheumatoid Arthritis and experienced Marasmus *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. Herpes Simplex (herpes simplex is a common viral infection): 2 people, 8.00%
  2. Depression: 2 people, 8.00%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.00%
  4. Pleural Effusion (water on the lungs): 1 person, 4.00%
  5. Insomnia (sleeplessness): 1 person, 4.00%
  6. Cardiac Failure Congestive: 1 person, 4.00%

Common drugs taken by these people *:

  1. Actemra: 8 people, 32.00%
  2. Simponi: 7 people, 28.00%
  3. Enbrel: 3 people, 12.00%
  4. Lansoprazole: 3 people, 12.00%
  5. Diovan: 2 people, 8.00%
  6. Furosemide: 2 people, 8.00%
  7. Isoniazid: 2 people, 8.00%
  8. Xeljanz: 2 people, 8.00%
  9. Luvox: 2 people, 8.00%
  10. Voltaren: 2 people, 8.00%

Common symptoms for these people *:

  1. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 3 people, 12.00%
  2. Haemorrhagic Diathesis (bleeding tendency): 2 people, 8.00%
  3. Nausea (feeling of having an urge to vomit): 2 people, 8.00%
  4. Drug Ineffective: 2 people, 8.00%
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 8.00%
  6. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 8.00%
  7. Infection Susceptibility Increased: 2 people, 8.00%
  8. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 8.00%
  9. Hypotension (abnormally low blood pressure): 2 people, 8.00%
  10. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Marasmus?

Check whether Marasmus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Marasmus:

All the drugs that are associated with Marasmus:

All the conditions that are associated with Marasmus:

How the study uses the data?

The study is based on Marasmus and Rheumatoid arthritis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: